Introduction
============

Psammocarcinoma of ovary is a rare serous neoplasm. Diagnosis requires the psammoma bodies to be present in at least 75% of papillae which show a destructive invasion of the ovarian stroma. The neoplastic cells do not show more than moderate atypia. There should be no areas of solid proliferation of neoplastic cells. These tumors are associated with a better prognosis than conventional serous neoplasms with low recurrence following tumor resection \[[@B1]\]. Literature search showed presence of only 28 cases of psammocarcinoma of ovary reported till date (Table [1](#T1){ref-type="table"}) \[[@B1]-[@B17]\]. This case will be another new one in the literature with serous cystadenofibroma of contralateral ovary and elevated levels of CA-125.

###### 

Literature review of primary ovarian psammocarcinomas

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                           Year   No.\    Age                     Clinical features                                                CA- 125 units/ml   FIGO stage   Surgery                                                             Chemothearpy           Follow up                                           Remarks
                                          of\                                                                                                                                                                                                                                                                             
                                          cases                                                                                                                                                                                                                                                                           
  -------------------------------- ------ ------- ----------------------- ---------------------------------------------------------------- ------------------ ------------ ------------------------------------------------------------------- ---------------------- --------------------------------------------------- ----------------------------------------------------------------------------
  Gilks et al \[[@B1]\]            1990   8       36 to 76 (mean of 57)   Abdominal pain                                                   NA                 III          TAH+ BSO (4 cases)\                                                 Y (1 patient)          1-died\                                             
                                                                                                                                                                           LSO(2 cases)\                                                                              3- lost FU\                                         
                                                                                                                                                                           BSO(2 cases)\                                                                              4- free of disease                                  
                                                                                                                                                                           Oment (3/8 cases)                                                                                                                              

                                                                                                                                                                                                                                                                                                                          

  Kelley et al \[[@B2]\]           1995   1       18                      Abdominal pain                                                   25                 IIIC         TAH, BSO, oment,                                                    Y                      42 months NED                                       Adolescent

                                                                                                                                                                                                                                                                                                                          

  Pakos et al \[[@B3]\] (German)   1997   1       49                      Mass in the lower abdomen                                                           IA           BSO                                                                 N                      NED                                                 

                                                                                                                                                                                                                                                                                                                          

  Powell et al \[[@B4]\]           1998   1       59                      Abdominal pain and increasing abdominal girth                    118                IIIB         TAH, BSO, oment                                                     N                      12 months NED                                       Family history of epithelial cancer positive

                                                                                                                                                                                                                                                                                                                          

  Poggi et al \[[@B5]\]            1998   1       66                      Abdominal Pain nausea vomiting                                   NA                 IIIB         BSO, oment                                                          N                      Recurrence 18 months                                Aggressive, with Cystadenofibromata

                                                                                                                                                                                                                                                                                                                          

  Cobellis et al \[[@B6]\]         2003   1       48                      Referred for leiomyomata uteri                                   Normal             IIIA         TAH, BSO, oment                                                     N                      2 years NED                                         Omental and peritoneal implant

                                                                                                                                                                                                                                                                                                                          

  Giordano et al \[[@B7]\]         2005   1       66                      Abdomino-pelvic mass                                             Elevated           IIIB         TAH, BSO, oment,                                                    Y                      NED after 1 year                                    Bilateral, omental nodule showed the features of invasive implant

                                                                                                                                                                                                                                                                                                                          

  Rattenmaier et al \[[@B8]\]      2005   1       70                      Malaise and abdominal discomfort                                 25,000             NA           AH, BSO                                                             N                      Recovered                                           Bilateral with cysadenofibromata

                                                                                                                                                                                                                                                                                                                          

  Radin et al \[[@B9]\]            2005   1       60                      Diffuse abdominal pain, bloating, diarrhea, and low back pain,   65.2               III          Laparotomy, tumor debulking                                         Y                      NA                                                  Aggressive

                                                                                                                                                                                                                                                                                                                          

  Vimplis et al\[[@B10]\]          2006   1       63                      Abdominal discomfort and increasing abdominal girth              1,133              IIIB         BSO,, SH, oment,                                                    Y                      NED                                                 

                                                                                                                                                                                                                                                                                                                          

  Hiromura et al \[[@B11]\]        2007   1       73                      Lower abdominal distention and pain                              464                IIIC         AH, BSO, and oment                                                  Y                      4 months stable                                     

                                                                                                                                                                                                                                                                                                                          

  Akbulut et al \[[@B12]\]         2007   1       67                      Vaginal bleeding and abdomino-pelvic pain                        175                IIIC         Debulking                                                           Y                      10 years with recurrent and metastatic disease      Aggressive

                                                                                                                                                                                                                                                                                                                          

  Pusiol et al \[[@B13]\]          2008   1       50                      NA                                                               NA                 IIIB         Laparotomy                                                          Y                      10.5 years, free of disease.                        Bilateral, psammoma bodies in cervical smear, Presence of psammocarcinoma\
                                                                                                                                                                                                                                                                                                                          in the tubaric lumen

                                                                                                                                                                                                                                                                                                                          

  Alanbay et al \[[@B14]\]         2009   2       41,50                   Adnexal mass, pelvic pain                                        NA, 3,223          III          Surgery                                                             Y                      6 years free of disease, 2 months                   

                                                                                                                                                                                                                                                                                                                          

  Tiro et al \[[@B15]\]            2009   1       58                      Shortness of breath                                              175.5              NA           N                                                                   Y                      NA                                                  Implants in pleural cavity and pericardium

                                                                                                                                                                                                                                                                                                                          

  Chase et al \[[@B16]\]           2009   1       45                      Subcutaneous nodule                                              NA                 NA           Bilateral salpingo-oophrectomy                                      Tamoxifen              NA                                                  Mediastinal, pulmonary, subcutaneous, and omental metastases

                                                                                                                                                                                                                                                                                                                          

  Poujade et al \[[@B17]\]         2009   4       19-67                   NA                                                               NA                 NA           Y                                                                   Y except in one case   18-45 months NED, one case has persistent disease   

                                                                                                                                                                                                                                                                                                                          

  Current case                     2009   1       50                      Menorrhagia, abdominal discomfort and pain                       995.4              I C          Total abdominal hysterectomy with bilateral salpingo oophorectomy   Y                      6 months, free of disease                           Contralteral cystadenofibroma
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: NA- Not available; TAH - Total abdominal hysterectomy; BSO- Bilateral salpingo- oophorectomy; Oment- Omentectomy; AH- Abdominal hysterectomy; Y- Yes; N- No; FU- Follow up; NED- No evidence of disease, LSO - left salpingo-oophorectomy; SH- Subtotal hysterectomy

Case presentation
=================

A 55-year-old Asian Indian female presented to gynecology clinic with complaints of menorrhagia, abdominal discomfort and pain. On Examination a mass was palpable in the lower abdomen which was non tender and fixed. Ultrasound (USG) examination revealed the presence of an abdomino-pelvic mass and ascites. Contrast-enhanced computed tomogram (CECT) revealed an abdominopelvic lobulated calcified mass measuring 17 × 15 × 16 cms (Fig [1a](#F1){ref-type="fig"}). Clinically, a possibility of calcified fibroid of uterus was suspected. However, cytologic examination of ascitic fluid was positive for malignant cells. On exploratory laparotomy, bilateral ovaries were enlarged with intact capsule. Total abdominal hysterectomy with bilateral salpingo-oophorectomy was performed. There were no retroperitoneal lymph nodes. No visible tumor nodules were identified on peritoneal surface. Grossly the left ovary was enlarged and measuring 24 × 20 × 20 cms. Outer surface was smooth and lobulated. Cut section was solid, grey white, gritty and granular with no visible necrosis (Fig [1b](#F1){ref-type="fig"}). The right ovary measured 7 × 6 × 2 cms. Cut section was solid and cystic with cysts ranging in size from 0.4 to 0.5 cm. The cysts were filled with clear fluid. No areas of hemorrhage or necrosis were seen in either of the two ovaries. Microscopically, sections from the left ovary revealed numerous psammoma bodies infiltrating the ovarian stroma and forming more than 95% of the tumor. At places these were lined by low cuboidal cells with minimal atypia (Fig [1c-f](#F1){ref-type="fig"}). No areas of necrosis, hemorrhage or increase mitosis were seen. Sections from the right ovary showed cysts lined by low cuboidal epithelium with prominence of fibroblastic stromal component. Thus a final diagnosis of psammocarcinoma of left ovary and serous cystadenofibroma of right ovary was made. Following the diagnosis, serum CA-125 was estimated which was elevated to 995.4 U/ml. Uterus showed a submucosal leiomyoma with proliferative endometrium on histology. Cervix and bilateral fallopian tubes were unremarkable grossly as well as microscopically. Patient received chemotherapy and kept on close follow up.

![**Computed tomography scan shows calcified abdominopelvic mass (a); gross photograph shows gritty and firm tumor (b); on histological examination, tumor reveals extensive psammoma bodies which are surrounded by single layer of cytologically bland cuboidal or low columnar epithelium (c-f) H&E cx40; dx100; ex400; fx600**.](1752-1947-3-9330-1){#F1}

Discussion
==========

Psammocarcinoma of ovary is a rare serous neoplasm which can arise from both peritoneum and ovaries \[[@B1]\]. Extensive search showed presence of only 28 cases of psammocarcinoma of ovary reported till date \[[@B1]-[@B17]\] (Table [1](#T1){ref-type="table"}). Age ranged from 18 to 76 years \[[@B1],[@B2]\]. Many of these cases presented with abdominal discomfort and increasing abdominal girth.

This tumor can be misdiagnosed as other calcifying tumors of abdomino-pelvic region especially calcified leiomyomas, by radiological investigations, similar to our case. However if calcified abdomino-pelvic tumors are seen in association with an elevated CA-125 level, then a diagnosis of ovarian neoplasm can be made \[[@B7]\]. In most of the reported cases CA-125 levels were raised ranging from 65-25,000 units/ml \[[@B7],[@B8]\]. Our patient had elevated levels of CA-125 just after the surgery.

Although most of the cases reported are unilateral, rarely these are bilateral \[[@B8],[@B13]\].

All but one, cases reported in the literature had FIGO stage III tumors showing clinical behavior similar to that of borderline serous tumors \[[@B3]\]. Our case fits in to stage I C as patient had malignant ascitis, however no pelvic extension was seen.

Despite the apparent low malignant potential of this tumor, there remains a need for patient\'s follow up data as aggressive behavior has been described in the literature \[[@B12],[@B15],[@B16]\]. In the case reported by Poggi et al \[[@B5]\] no adjuvant therapy was given because of the supposed indolent behavior. However, recurrence of disease has been noted after eighteen months. Our patient received post operative adjuvant therapy and is on follow up.

Histopathologic differential diagnosis of psammocarcinoma involves other serous epithelial tumors. Some rare cystadenofibromas have mild cytologic atypia and may also exhibit psammoma bodies, but they are generally inconspicuous. In the present case we have seen cystadenofibroma in the contralateral ovary with an occasional psammoma body formation. Earlier, association of psammocarcinoma with cystadenofibroma has been documented \[[@B5],[@B8]\]. Although these tumors show clinical behavior similar to that of borderline serous tumors, the presence of destructive stromal invasion excludes serous borderline tumors. Moderate cytologic atypia helps differentiating from high grade serous carcinomas. Psammocarcinomas differ from well-differentiated serous adenocarcinomas by numerous psammoma body formations.

Potential mechanisms responsible for the characteristic, extensive psammoma body formation include the accumulation of successive layers of calcium on single necrotic or degenerated tumor cells. One hypothesis states that they arise due to accumulation of hydroxyapatite in degenerating cells \[[@B18]\]. Psammoma bodies are described as multiple, discrete, laminated calcified bodies and are found in many neoplastic and non neoplastic lesions. Characteristic calcifications on radiological investigations and psammoma bodies on cervicovaginal smears should alert the clinician for this unusual tumor. Recently Pusiol et al \[[@B13]\] have reported a case of psammocarcinoma associated with presence of psammoma bodies in the cervicovaginal smears.

The molecular features of psammocarcinoma include mutations of a gene belong to the cancer related RAF family, that is BRAF \[[@B19]\].

Hiromura et al \[[@B11]\] described imaging features of psammocarcinoma including extensive minute calcifications on CT scan that were not detected on the abdominal x-ray. The tumor appears sandy and coarsely granular on enhanced T1-weighted MR images due to scattered clusters of psammomatous calcifications. Radin et al \[[@B9]\] have shown its high avidity for the Tc-99m MDP radiopharmaceutical.

Like with other serous epithelial tumors of the ovary, aggressive debulking surgery has been the initial treatment modality in nearly all cases. Postoperative therapies have included observation, tamoxifen and cytotoxic chemotherapy (generally using cyclophosphamide with cisplatin or carboplatin) \[[@B4]\].

Conclusion
==========

Psammocarcinomas are rare serous neoplasms. Due to the rare aggressive nature of the tumor, it is important to follow up the patient closely. Our case adds a new case of psammocarcinoma with contralateral cysadenofibroma in the literature.
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